Wordt geladen...
Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()
Radiotherapy (XRT) delivered with the antibody cetuximab is a standard treatment option for squamous cell carcinomas of head and neck (SCCNH). Cetuximab acts by blocking epidermal growth factor receptor (EGFR) signaling to inhibit cancer progression. However, a significant percentage of patients wil...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Neoplasia Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4202798/ https://ncbi.nlm.nih.gov/pubmed/25171892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.02.008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|